Maven Clinic Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Brand-name GLP-1 integrated into women's and family virtual care
Maven Clinic scores highest on the strength of its clinical program — drug options and dosing support.
What the plan covers
Medication
Billed separately
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Maven Clinic is a virtual women's and family health platform (fertility, maternity, menopause, pediatrics) used by 2,300+ employers that also runs a dedicated GLP-1 Care program. It pairs brand-name GLP-1 prescriptions (Wegovy, Ozempic, Zepbound and Foundayo) with on-demand metabolic and hormone-health specialists plus nutrition and strength support. It is offered through employer benefits or as a self-pay membership of $39 for the first month, then $150 a month, with medication billed separately. LegitScript-certified.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Maven Clinic
altRX
Best for: low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Luvo Health
Best for: compounded and brand GLP-1s, oral tablets and microdosing on one public price list
Editorial score · methodology
Maven Clinic at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Program fee
- $150/mo ($39 first month; Maven GLP-1 program membership (medication billed separately))
- What's included
- Consult · Coaching
- FDA status
- No FDA warning letter on record
How we scored Maven Clinic
Each dimension is scored algorithmically from Maven Clinic’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.2/10Maven Clinic does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.3/10Maven Clinic offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.0/10Maven Clinic's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
7.7/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Maven Clinic review
Last checked October 2026- Confirmed current pricing across 1 dose/plan tier
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $150/mo across 1 dose/plan tier — checked October 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
GLP-1 medications Maven Clinic offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
"$39 first month", then "$150 per month". Prepaid plans: $99 a month for 3 months ($297), $89 a month for 6 months ($534), $74 a month for 12 months ($888). Medication is billed separately, from $149 a month self-pay or as low as $25 a month with insurance.
Ready to get started?
Plans and promotions change often — check Maven Clinic's current pricing and active discounts before you decide.
What we like
- Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions, including Wegovy, Ozempic, Zepbound and Foundayo
- On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
- Publishes its self-pay membership price and a per-dose self-pay price list for each medication
- Integrated with broader women's, hormone, and family health care
- LegitScript-certified; trusted by 2,300+ employers
- Available as both an employer health benefit and a consumer self-pay option
Watch-outs
- Medication is billed on top of the membership, starting at $149 a month self-pay and rising with the drug and dose
- Primarily distributed through employers and health plans — direct access can depend on your plan
- US state availability for GLP-1 is not specified publicly
- Brand-name only — no lower-cost compounded option
Maven Clinic: a women's and family health platform that added serious GLP-1 care
Maven Clinic is not a stripped-down weight-loss storefront, and that is the single most important thing to understand before you sign up. It is a virtual women's and family health platform — fertility, maternity, menopause, pediatrics, hormone care — that now runs a dedicated GLP-1 Care program inside that larger clinic. If you want a quick, cheap monthly injection and nothing else, this is probably not your provider. If you want GLP-1 treatment that sits alongside real specialist support and broader hormone and family health, Maven is built for exactly that.
The trade-off is baked into the model: Maven prescribes brand-name, FDA-approved GLP-1s only — Wegovy, Ozempic, Zepbound and the oral drug Foundayo — and says it does not offer compounded formulations. That makes it a fundamentally different choice from the compounding-pharmacy providers that dominate this category on price.
How you actually get in: employer benefit or self-pay
Maven reaches most people two ways, and which one applies to you changes everything about cost and access. The first is through your employer or health plan — Maven is trusted by more than 2,300 employers across 175+ countries, and in that setup GLP-1 Care shows up as a covered benefit, often at no direct cost to you. The second, newer track is Maven Consumer, a self-pay option the company recently launched ("Maven Consumer is now live") for people whose employer doesn't offer it.
So the honest first question isn't "how good is Maven?" — it's "does my employer already offer it?" If they do, you may have access to specialist-backed GLP-1 care for free. If they don't, you can still come in through the self-pay door, but you'll be paying out of pocket for both the program and the brand-name medication.
What the price actually is
For the employer-benefit track, your cost is whatever your plan sets — frequently nothing. For Maven Consumer self-pay, Maven publishes its prices. The GLP-1 Care membership is $39 for the first month, then $150 a month, and prepaying for 3, 6 or 12 months lowers it, to as little as $74 a month on the 12-month plan. The brand-name medication is billed on top of that, either through your insurance or at Maven's published self-pay prices, which start at $149 a month at the lowest doses and rise with the drug and dose. For context, the typical published self-pay rate across the providers we track sits around $179 a month — but those are almost always compounded programs that include the drug, so it isn't an apples-to-apples comparison with Maven's membership-plus-medication model. If your clinician decides GLP-1s aren't a fit, Maven says you may qualify for a refund.
How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 508 GLP-1 providers we track.
The medications and how they're dispensed
Maven works with brand-name semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound) and orforglipron (Foundayo) — the FDA-approved branded products, not pharmacy-compounded versions. A clinician prescribes, and the medication is filled and billed through normal pharmacy channels rather than mailed from a compounding partner. That's why there's no single bundled "medication included" price: the visit/program side and the drug side are separate line items.
- Brand-name only — no compounded semaglutide or tirzepatide, so you don't get the deep discounts compounders offer, but you also avoid the regulatory gray area around compounding
- On-demand visits with metabolic and hormone-health specialists, not just a one-time prescriber
- Nutrition and strength support built into the program, not sold as an add-on
- Integrated with Maven's broader hormone, women's, and family health services
What genuinely sets Maven apart
The real differentiator is the wraparound care. Most GLP-1 telehealth is transactional — a questionnaire, a prescription, a refill. Maven's GLP-1 Care pairs the medication with repeated, on-demand access to metabolic and hormone-health specialists plus dedicated nutrition and strength coaching, and it lives inside a platform already handling fertility, menopause, and family health. For someone managing weight alongside perimenopause, PCOS, a fertility journey, or postpartum changes, having one platform connect those threads is a legitimately different value proposition than a standalone injection service.
Who should choose Maven — and who should skip it
Choose Maven if your employer offers it (the value at little or no cost is hard to beat), or if you specifically want brand-name GLP-1 treatment integrated with women's and family health and you're willing to pay for that depth. It's a strong fit for people who want specialist oversight and coordinated hormone care, not just a script.
Skip Maven if price is your top priority — brand-name-only means you'll pay far more than a compounded program once the membership and the medication are added together. Also think twice if you need certainty about access in your state: Maven does not publicly specify which US states its GLP-1 program covers, so confirm availability before you count on it.
Trust, safety, and medical oversight
On the safety side, Maven scores well. It is LegitScript-certified, which signals it meets recognized standards for legitimate online healthcare and pharmacy practice. There are no FDA warning letters on file against it. Prescribing brand-name FDA-approved medications (rather than compounded) further reduces formulation risk. The one knock is transparency on access. With no public state list, you're trusting the intake process to confirm whether the program covers you. You can see how we weigh these factors in our scoring methodology.
Bottom line
Maven Clinic is one of the more credible, clinically serious GLP-1 options we track — but it's a benefits-driven, brand-name program, not a budget play. If your employer covers it, it's close to a no-brainer: specialist-backed GLP-1 care wrapped into a full women's and family health platform, often at no direct cost. If you're paying out of pocket, go in clear-eyed about the brand-name premium, add the membership and your medication price together, and get a state-availability confirmation from Maven before you commit.
For a side-by-side, Collective ($59/month) is a comparable option to weigh against Maven Clinic.
The Bottom Line
Maven Clinic scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Maven Clinic?
See current pricing and start your free consultation.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Maven Clinic review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Maven Clinic's current pricing
Start your free consultation to check eligibility and today's price.